BeVigilant RAPID Test + RAPID Reader

Transform Early Detection of Oral Cancer

Easy To Use and Easy To Add To Your Practice

Most adults should be tested annually for oral cancer. The BeVigilant RAPID Platform can aid clinicians in assessing patients who exhibit certain conditions which may lead to oral and oropharyngeal cancer. These conditions include oral potentially malignant disorders (OPMD), presence of an oral lesion, symptomatic conditions, and/or patients who have multiple known risk factors.
The BeVigilant RAPID Platform includes the pointofcare BeVigilant RAPID Test, the advanced immunochromatography RAPID Reader and the BeVigilant Portal.
Most adults should be tested annually for oral cancer. The BeVigilant RAPID Platform can aid clinicians in assessing patients who exhibit certain conditions which may lead to oral and oropharyngeal cancer. These conditions include oral potentially malignant disorders (OPMD), presence of an oral lesion, symptomatic conditions, and/or patients who have multiple known risk factors.
The BeVigilant RAPID Platform includes the pointofcare BeVigilant RAPID Test, the advanced immunochromatography RAPID Reader and the BeVigilant Portal.

The BeVigilant RAPID Test + RAPID Reader is a value-added offering you can integrate easily into your practice as part of your patients’ regular care.

The BeVigilant RAPID Test + RAPID Reader is a value-added offering you can integrate easily into your practice as part of your patients’ regular care.

Complements regular checkups for a more comprehensive oral exam
Quickly identifies patients who may need additional follow-up
May benefit at-risk adults (i.e. current and former tobacco users, those who consume excessive alcohol, or people with human papillomavirus)
Advanced immunochromatography reader reports test results during the patient visit
Web portal stores and tracks patient’s results over time

The BeVigilant RAPID Test aids in early detection allowing the patient the opportunity to adjust his/her lifestyle to mitigate risks of developing oral cancer

Not Available for Sale in the U.S.

The BeVigilant RAPID Test aids in early detection allowing the patient the opportunity to adjust his/her lifestyle to mitigate risks of developing oral cancer

Not Available for Sale in the U.S.

Order Now to Start Testing Your At-Risk Patients Today!

ReaderImage_revised
© 2020 Vigilant Biosciences

Follow Us

3900001 Rev1